FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Oct 24, 2019
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on October 24, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- October 24, 2019
- Product Type
- Biologics
View Company Profile
ID · 111b4139-3abd-460f-9399-a584cf77aa5a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1107384
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2017 | Not classified | Florida District Office |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1017693 - 2017-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.